{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T01:57:52Z","timestamp":1790474272416,"version":"4.1.0"},"reference-count":117,"publisher":"Wiley","issue":"4","license":[{"start":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T00:00:00Z","timestamp":1532390400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100008363","name":"Kr\u00e6ftens Bek\u00e6mpelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008363","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["J Intern Med"],"published-print":{"date-parts":[[2018,10]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p><jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> is the current state\u2010of\u2010the\u2010art imaging in lymphoma and plays a central role in treatment decisions. At diagnosis, accurate staging is crucial for appropriate therapy selection: <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> can identify areas of lymphoma missed by <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> alone and avoid under\u2010treatment of patients with advanced disease stage who would have been misclassified as having limited stage disease by <jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content>. Particularly in Hodgkin lymphoma, positive interim <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> scans are adversely prognostic for clinical outcomes and can inform <jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\u2010adapted treatment strategies, but such data are less consistent in diffuse large B\u2010cell lymphoma. The use of quantitative <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> metrics using metabolic tumour volume, possibly in combination with other biomarkers, may better define prognostic subgroups and thus facilitate better treatment selection. After chemotherapy, <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> response is predictive of outcome and may identify a subgroup who benefit from consolidative radiotherapy. Novel therapies, in particular immunotherapies, exhibit different response patterns than conventional chemotherapy, which has led to modified response criteria that take into account the risk of transient pseudo\u2010progression. In relapsed lymphoma, <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> after second\u2010line therapy and prior to high\u2010dose therapy is also strongly associated with outcome and may be used to guide intensity of salvage therapy in relapsed Hodgkin lymphoma. Currently, <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> has no role in the routine follow\u2010up after complete metabolic response to therapy, but it remains a powerful tool for excluding relapse if patients develop clinical features suggestive of disease relapse. In conclusion, <jats:styled-content style=\"fixed-case\">FDG<\/jats:styled-content>\u2010<jats:styled-content style=\"fixed-case\">PET<\/jats:styled-content>\/<jats:styled-content style=\"fixed-case\">CT<\/jats:styled-content> plays major roles in the various phases of management of lymphoma and constitutes a step towards the pursuit of personalized treatment.<\/jats:p>","DOI":"10.1111\/joim.12813","type":"journal-article","created":{"date-parts":[[2018,7,10]],"date-time":"2018-07-10T10:54:19Z","timestamp":1531220059000},"page":"358-376","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":126,"title":["<scp>FDG<\/scp>\u2010<scp>PET<\/scp>\/<scp>CT<\/scp> in the management of lymphomas: current status and future directions"],"prefix":"10.1111","volume":"284","author":[{"given":"T. C.","family":"El\u2010Galaly","sequence":"first","affiliation":[{"name":"Department of Hematology Aalborg University Hospital Aalborg Denmark"},{"name":"Clinical Cancer Research Center Aalborg University Hospital Aalborg Denmark"},{"name":"Department of Clinical Medicine Aalborg University Aalborg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Villa","sequence":"additional","affiliation":[{"name":"Division of Medical Oncology and Centre for Lymphoid Cancer BC Cancer Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L. C.","family":"Gormsen","sequence":"additional","affiliation":[{"name":"Department of Nuclear Medicine and PET Centre Aarhus University Hospital Aarhus Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Baech","sequence":"additional","affiliation":[{"name":"Department of Hematology Aalborg University Hospital Aalborg Denmark"},{"name":"Clinical Cancer Research Center Aalborg University Hospital Aalborg Denmark"},{"name":"Department of Clinical Medicine Aalborg University Aalborg Denmark"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Lo","sequence":"additional","affiliation":[{"name":"Division of Radiation Oncology BC Cancer Vancouver BC Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Y.","family":"Cheah","sequence":"additional","affiliation":[{"name":"Department of Haematology Sir Charles Gairdner Hospital and Pathwest Laboratory Medicine Nedlands WA Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2018,7,24]]},"reference":[{"key":"e_1_2_12_2_1","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Carbone PP","year":"1971","journal-title":"Cancer Res"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1989.7.11.1630"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.54.8800"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.5229"},{"key":"e_1_2_12_6_1","first-page":"1860","article-title":"Report of the committee on Hodgkin's disease staging classification","volume":"31","author":"Tubiana M","year":"1994","journal-title":"Cancer Res"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.109.067892"},{"key":"e_1_2_12_8_1","first-page":"1267","article-title":"Detection of Richter's transformation of chronic lymphocytic leukemia by PET\/CT","volume":"47","author":"Bruzzi JF","year":"2006","journal-title":"J Nucl Med"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-11-679407"},{"key":"e_1_2_12_10_1","first-page":"482","article-title":"Position emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma","volume":"91","author":"Hutchings M","year":"2006","journal-title":"Haematologica"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.42.4036"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12483"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1157\/13112510"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdj024"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdn282"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdu181"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdv304"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.767901"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw137"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.113.134486"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2012-12-473389"},{"key":"e_1_2_12_22_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24128"},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx223"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2007.09.051"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdt137"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_10"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198506203122504"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.111.088914"},{"key":"e_1_2_12_29_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-016-3315-7"},{"key":"e_1_2_12_30_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2705-y"},{"key":"e_1_2_12_31_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2961-x"},{"key":"e_1_2_12_32_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-011-1899-5"},{"key":"e_1_2_12_33_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-773838"},{"key":"e_1_2_12_34_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-06-788877"},{"key":"e_1_2_12_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-07-795476"},{"key":"e_1_2_12_36_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12467"},{"key":"e_1_2_12_37_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12268"},{"key":"e_1_2_12_38_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-014-2822-7"},{"key":"e_1_2_12_39_1","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.20447"},{"key":"e_1_2_12_40_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.66.9440"},{"key":"e_1_2_12_41_1","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdw011"},{"key":"e_1_2_12_42_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-06-2252"},{"key":"e_1_2_12_43_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2007.11.6525"},{"key":"e_1_2_12_44_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1408648"},{"key":"e_1_2_12_45_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.68.6394"},{"key":"e_1_2_12_46_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.4817"},{"key":"e_1_2_12_47_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1100340"},{"key":"e_1_2_12_48_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1510093"},{"key":"e_1_2_12_49_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2017.75.2543"},{"key":"e_1_2_12_50_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(17)32134-7"},{"key":"e_1_2_12_51_1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1182\/blood.V126.23.577.577","article-title":"Randomized Phase III Study Comparing an Early PET driven treatment de\u2010escalation to a Not PET\u2010monitored strategy in patients with advanced stages Hodgkin Lymphoma: interim analysis of the AHL2011 Lysa study","volume":"126","author":"Casasnovas O","year":"2015","journal-title":"Blood"},{"key":"e_1_2_12_52_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2838"},{"key":"e_1_2_12_53_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(16)30108-9"},{"key":"e_1_2_12_54_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-03-276246"},{"key":"e_1_2_12_55_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(11)70235-2"},{"key":"e_1_2_12_56_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.1618"},{"key":"e_1_2_12_57_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.58.9846"},{"key":"e_1_2_12_58_1","doi-asserted-by":"publisher","DOI":"10.2967\/jnumed.114.145326"},{"key":"e_1_2_12_59_1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1182\/blood.V124.21.391.391","article-title":"Positron emission tomography (PET) guided therapy of aggressive lymphomas\u2010a randomized controlled trial comparing different treatment approaches based on interim PET results (PETAL trial)","volume":"124","author":"Duehrsen U","year":"2014","journal-title":"Blood"},{"key":"e_1_2_12_60_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2016.154039"},{"key":"e_1_2_12_61_1","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1182\/blood.V124.21.392.392","article-title":"Phase 2 trial of interim PET scan\u2010tailored therapy in patients with advanced stage diffuse large B\u2010cell lymphoma (DLBCL) in British Columbia (BC)","volume":"124","author":"Sehn LH","year":"2014","journal-title":"Blood"},{"key":"e_1_2_12_62_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-02-766691"},{"key":"e_1_2_12_63_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.26.5942"},{"key":"e_1_2_12_64_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13389"},{"key":"e_1_2_12_65_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13036"},{"key":"e_1_2_12_66_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2013.862242"},{"key":"e_1_2_12_67_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2008.11.026"},{"key":"e_1_2_12_68_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-010-1490-5"},{"key":"e_1_2_12_69_1","doi-asserted-by":"publisher","DOI":"10.1038\/35000501"},{"key":"e_1_2_12_70_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-12-820605"},{"key":"e_1_2_12_71_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.53.2507"},{"key":"e_1_2_12_72_1","doi-asserted-by":"publisher","DOI":"10.3109\/10428194.2011.603444"},{"key":"e_1_2_12_73_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2008-06-155820"},{"key":"e_1_2_12_74_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2441060810"},{"key":"e_1_2_12_75_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V98.10.2930"},{"key":"e_1_2_12_76_1","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.2001.03169.x"},{"key":"e_1_2_12_77_1","doi-asserted-by":"publisher","DOI":"10.1023\/A:1008357126404"},{"key":"e_1_2_12_78_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61940-5"},{"key":"e_1_2_12_79_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2009.27.3441"},{"key":"e_1_2_12_80_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.02.007"},{"key":"e_1_2_12_81_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2011.12.067"},{"key":"e_1_2_12_82_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2013.51.4505"},{"key":"e_1_2_12_83_1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1182\/blood.V130.Suppl_1.823.823","article-title":"Long\u2010term results of PET\u2010guided radiation therapy in patients with advanced\u2010stage diffuse large B\u2010Cell lymphoma treated with R\u2010CHOP in British Columbia","volume":"130","author":"Freeman CL","year":"2017","journal-title":"Blood"},{"key":"e_1_2_12_84_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.2437_119"},{"key":"e_1_2_12_85_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.V124.21.393.393"},{"key":"e_1_2_12_86_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00259-003-1169-2"},{"key":"e_1_2_12_87_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2016-05-718528"},{"key":"e_1_2_12_88_1","doi-asserted-by":"publisher","DOI":"10.1259\/bjr\/86221320"},{"key":"e_1_2_12_89_1","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/231090"},{"key":"e_1_2_12_90_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.06.044"},{"key":"e_1_2_12_91_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.04.026"},{"key":"e_1_2_12_92_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2009.11.048"},{"key":"e_1_2_12_93_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2010.02.024"},{"key":"e_1_2_12_94_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2006.05.015"},{"key":"e_1_2_12_95_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.radonc.2008.05.012"},{"key":"e_1_2_12_96_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2013.05.005"},{"key":"e_1_2_12_97_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijrobp.2014.01.006"},{"key":"e_1_2_12_98_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2012.45.2714"},{"key":"e_1_2_12_99_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2014.55.7561"},{"key":"e_1_2_12_100_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1991.9.7.1196"},{"key":"e_1_2_12_101_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2015.62.0229"},{"key":"e_1_2_12_102_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-010-1044-8"},{"key":"e_1_2_12_103_1","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2013.338"},{"key":"e_1_2_12_104_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-014-2040-1"},{"key":"e_1_2_12_105_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.23423"},{"key":"e_1_2_12_106_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.12687"},{"key":"e_1_2_12_107_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2011.056010"},{"key":"e_1_2_12_108_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2008.16.1513"},{"key":"e_1_2_12_109_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.14132154"},{"key":"e_1_2_12_110_1","first-page":"1501","article-title":"Surveillance imaging during first\u2010remission in follicular lymphoma does not impact overall survival","volume":"130","author":"Goldman ML","year":"2017","journal-title":"Blood"},{"key":"e_1_2_12_111_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.23861"},{"key":"e_1_2_12_112_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.2010.08162.x"},{"key":"e_1_2_12_113_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-606939"},{"key":"e_1_2_12_114_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70013-6"},{"key":"e_1_2_12_115_1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.15108"},{"key":"e_1_2_12_116_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801445"},{"key":"e_1_2_12_117_1","doi-asserted-by":"publisher","DOI":"10.1038\/nrc.2017.127"},{"key":"e_1_2_12_118_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1470-2045(15)70106-3"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fjoim.12813","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/joim.12813","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T20:56:04Z","timestamp":1694984164000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/joim.12813"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,24]]},"references-count":117,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["10.1111\/joim.12813"],"URL":"https:\/\/doi.org\/10.1111\/joim.12813","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,24]]},"assertion":[{"value":"2018-07-24","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}